Long Focus Capital Management, LLC Anixa Biosciences Inc Transaction History
Long Focus Capital Management, LLC
- $2.73 Billion
- Q3 2024
A detailed history of Long Focus Capital Management, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 165,701 shares of ANIX stock, worth $526,929. This represents 0.02% of its overall portfolio holdings.
Number of Shares
165,701
Previous 165,701
-0.0%
Holding current value
$526,929
Previous $366,000
42.35%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.53MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.43 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.13 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.97 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.68 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.62 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $97.5M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...